N-Methyl-DL-Aspartic Acid

ʻO ka wehewehe pōkole:

ʻO ka N-Methyl-DL-Aspartic Acid (NMA) kahi mea hoʻoheheʻe amino acid i nā holoholona a he homologue o L-Glutamic Acid, kahi neurotransmitter excitatory koʻikoʻi i loko o ka ʻōnaehana nerve waena mammalian. He mea koʻikoʻi ia no kāna mau waiwai neurogenic, ʻo ia ka mea e hoʻoikaika ai i ka ulu a me ka ulu ʻana o nā pūpū lolo. He wahi kēia derivative amino acid i ka synthesis protein a me nā neurotransmitters i ka lolo e like me ka glutamate a me ka aspartate. He amino acid derivative a excitatory neurotransmitter. Hiki i ka nui o ka NMDA ke hoʻoikaika nui i ka huna ʻana o ka hormone ulu holoholona (GH) a hoʻonui i ke kiʻekiʻe o GH i ke koko. Eia hou, hiki i ka N-methyl-DL-aspartic acid ke hoʻoikaika i ka ulu ʻana o ka muscl*e iwi a hoʻonui i ka nui o ka ʻiʻo a me ka ikaika.

ʻO ka N-Methyl-DL-Aspartic Acid (NMDA) he amino acid derivative i hana maoli ʻia i loko o nā holoholona, ​​​​a he neurotransmitter excitatory koʻikoʻi L-glutamic acid homologue i ka mammalian central nervous system. ʻōnaeʻa makaʻu. He mea kūpono ke haʻi ʻia he mau waiwai neurogenic, ʻo ia ka mea e hoʻoikaika ai i ka ulu a me ka ulu ʻana o nā pūpū lolo. He kuleana koʻikoʻi kēia derivative amino acid i ka synthesis o nā protein a me ka hoʻoponopono ʻana o nā neurotransmitters i ka lolo, e like me ka glutamate a me ka aspartate. He amino acid derivative a excitatory neurotransmitter. Hiki i ka nui kūpono o NMDA ke hoʻopilikia i ka ʻōnaehana endocrine o ke kino, ʻoi aku ka nui o ka hoʻoikaika ʻana i ka huna ʻana o ka hormone ulu holoholona (GH), e hoʻonui ana i ke kiʻekiʻe o GH i ke koko. Eia kekahi, hiki i ka N-methyl-DL-aspartic acid ke hoʻoikaika i ka ulu ʻana o ka ʻiʻo skeletal a hoʻonui i ka nui a me ka ikaika. Hiki i ka N-methyl-DL-aspartic acid ke hoʻomaikaʻi i ka pale ʻana a hoʻonui i ke kūpaʻa o ke kino a me ka hana pale.

 


  • Kumukuai FOB:US 5 - 2000 / KG
  • Ka nui o ke kauoha:1 KG
  • Hiki ke hoolako:10000 KG/no ka mahina
  • Awa:Shanghai/Beijing
  • ʻŌlelo Uku:L/C, D/A, D/P, T/T, O/A
  • Nā ʻōlelo hoʻouna:Ma ke kai/Ma ka Ea/Ma ka Luna Kiekie
  • E-mail:: info@trbextract.com
  • Huahana Huahana

    Huahana Huahana

    inoa huahana:N-Methyl-DL-Aspartic Acid

    ʻAʻohe CAS:17833-53-3

    Inoa ʻē aʻe: N-methyl-D, L-aspartate;

    N-methyl-D, L-aspartic acid;

    L-Aspartic acid, N-methyl;

    DL-Aspartic acid, N-methyl;

    DL-2-METHYLAMINOSUCCINIC ACID;

    Nā kikoʻī: 98.0%

    Kala: ʻO ka pauka keʻokeʻo me ke ʻala a me ka ʻono

    Kūlana GMO: ʻAʻole GMO

    Hoʻopili: ma 25kgs fiber drums

    Ka mālama ʻana: E mālama i ka pahu i wehe ʻole ʻia ma kahi maloʻo a maloʻo, e haʻalele i ka mālamalama ikaika

    Ola Ola: 24 mahina mai ka lā i hana ʻia

     

    N-Methyl-DL-Aspartic Acid (NMA) |NMDAReceptor Agonist for Neuroscience Research
    Huahana Huahana: NMA-2025 | CAS:17833-53-3| Maʻemaʻe: ≥98%

    Nānā Huahana

    ʻO N-Methyl-DL-Aspartic Acid (NMA), i ʻike ʻia ʻo DL-2-Methylaminosuccinic Acid, he analogue glutamate synthetic a me kahi agonist receptor NMDA potent. Hoʻohana nui ʻia i ka noiʻi neurobiological e aʻo i ka synaptic plasticity, neuronal excitotoxicity, a me nā ʻano maʻi e like me ka ʻeha neuropathic a me ka degeneration retinal.

    Nā mea nui

    • Maʻemaʻe Kiʻekiʻe: Hoʻāʻo ikaika ʻia ma o ka HPLC (≥98% maʻemaʻe) e hōʻoia i ka paʻa ʻana i nā hopena hoʻokolohua.
    • Nā mea hoʻohana nui: kūpono noin vitroain vivonā haʻawina, me ka hoʻokomo ʻana i ka locomotion fictive i loko o nā ʻupena spinal cord, ka nānā ʻana i ka neural circuitry maternal behavior, a me ka hoʻohālikelike ʻana i nā pōʻino retinal.
    • Hoʻokō Nā Kūlana Kūlohelohe: Loaʻa ʻia mai nā lako i hōʻoia ʻia e ISO, me ka hiki ke ʻike piha a me nā palapala MSDS.

    Nā noi ma ka noiʻi

    1. Neuropharmacology:
      • Hoʻopuka i ka locomotion fictive i loko o nā iwi kuamoʻo kaʻawale ke hoʻopili pū me 5-HT (e laʻa, 10 µM NMA + 10 µM 5-HT) .
      • Hoʻomaʻamaʻa i ka hoʻoulu ʻana o ka receptor NMDA i nā haʻawina o ka excitotoxicity a me ka neuroprotection.
    2. ʻO ka Neuroscience Behavioral:
      • Hoʻohana ʻia i nā ʻeha excitotoxic (e laʻa, MPOA ablation) e noiʻi i nā ʻano hana makuahine.
    3. Hoʻohālike maʻi:
      • Hoʻoulu i ka degeneration cell retinal i nā ʻano holoholona no ke aʻo ʻana i nā maʻi neurodegenerative.

    Nā Kūlana ʻenehana

    ʻĀpana kikoʻī
    ʻĀpana Molekala C₅H₉NO₄
    Kaumaha Molekala 147.13 g/mol
    Nā huaʻōlelo like DL-2-Methylaminosuccinic Acid, NMA
    Waihona E mālama i ka -20 ° C ma kahi maloʻo
    Nā Koho Packaging 10 mg, 50 mg, 100 mg (Hiki ke hoʻololi ʻia)

    No ke aha e koho ai iā mākou?

    • 15+ Makahiki o ka Hoʻonaʻauao: Ma ke ʻano he mea hoʻolako hilinaʻi i nā kemika noiʻi, hana mua mākou i ka pane wikiwiki a me nā hoʻonā kūpono no nā mea kūʻai aku a me nā ʻoihana.
    • Loaʻa: Hoʻonohonoho ʻia nā wehewehe huahana me nā huaʻōlelo (NMDA agonist, kemika noiʻi neuroscience) e hoʻonui i ka ʻike ma Google a me nā ʻikepili ʻepekema.

    Nā Huahana Pili

    • 5-Hydroxytryptamine (5-HT): Hoʻohana synergistic me NMA i nā haʻawina locomotion.
    • Calcium 2AEP & Astaxanthin: E ʻimi i kā mākou kōpili pūhui neuroprotective.

  • Mua:
  • Aʻe: